Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 18 04:05
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 11 04:03
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Apr 10 04:05
Clearmind Medicine | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Mar 28 04:40
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 28 04:05
Clearmind Medicine | EFFECT: Others
Mar 25 18:03
Clearmind Medicine | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Mar 21 04:58
Clearmind Medicine | 6-K: Report of foreign private issuer (related to financial reporting)
Mar 20 00:45
Clearmind Medicine | 20-F/A: Registration statement / Annual report / Transition report (Amendment)
Mar 19 05:22
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Mar 14 04:05
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 28 05:02
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 24 05:07
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 21 05:09
Clearmind Medicine | EFFECT: Others
Feb 20 19:03
Clearmind Medicine | CORRESP: CORRESP
Feb 15 11:21
Clearmind Medicine | UPLOAD: Others
Feb 15 11:16
Clearmind Medicine | SC 13G: Statement of acquisition of beneficial ownership by individuals-AdvisorShares Trust(5.48%)
Feb 15 00:12
Clearmind Medicine | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Feb 10 05:05
Clearmind Medicine | D: Filing D
Feb 8 02:46
Clearmind Medicine | F-1: Registration statement for securities of certain foreign private issuers
Feb 7 20:35
No Data
No Data